Lv C - Search Results

1

The variance of peripheral blood lymphocyte subsets of streptozotocin-induced diabetic mice after bone marrow transplantation.

Wang J, Lv C, Xie T, Ouyang J. Wang J, et al. Among authors: lv c. Int J Clin Exp Med. 2015 Mar 15;8(3):4115-21. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26064318 Free PMC article.

2

Bone marrow transplantation reverses new-onset immunoinflammatory diabetes in a mouse model.

Lv CL, Wang J, Xie T, Ouyang J. Lv CL, et al. Int J Clin Exp Pathol. 2014 Jul 15;7(8):5327-36. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25197419 Free PMC article.

3

Dysplastic changes in erythroid precursors as a manifestation of lead poisoning: report of a case and review of literature.

Lv C, Xu Y, Wang J, Shao X, Ouyang J, Li J. Lv C, et al. Int J Clin Exp Pathol. 2015 Jan 1;8(1):818-23. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 25755780 Free PMC article. Review.

4

Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide: A case report.

Xu J, Xu X, Chen J, Wang J, Jiang C, Lv C, Chen B. Xu J, et al. Among authors: lv c. Medicine (Baltimore). 2021 Mar 12;100(10):e24824. doi: 10.1097/MD.0000000000024824. Medicine (Baltimore). 2021. PMID: 33725836 Free PMC article.

5

Successful Management of a Patient with Refractory Primary Central Nervous System Lymphoma by Zanubrutinib.

Cheng Q, Wang J, Lv C, Xu J. Cheng Q, et al. Among authors: lv c. Onco Targets Ther. 2021 May 24;14:3367-3372. doi: 10.2147/OTT.S309408. eCollection 2021. Onco Targets Ther. 2021. PMID: 34079282 Free PMC article.

6

Primary central nervous system lymphoma in the United States, 1975-2017.

Lv C, Wang J, Zhou M, Xu JY, Chen B, Wan Y. Lv C, et al. Ther Adv Hematol. 2022 Jan 23;13:20406207211066166. doi: 10.1177/20406207211066166. eCollection 2022. Ther Adv Hematol. 2022. PMID: 35096360 Free PMC article.

7

N6-methyladenosine regulators are potential prognostic biomarkers for multiple myeloma.

Wang J, Zuo Y, Lv C, Zhou M, Wan Y. Wang J, et al. Among authors: lv c. IUBMB Life. 2023 Feb;75(2):137-148. doi: 10.1002/iub.2678. Epub 2022 Oct 8. IUBMB Life. 2023. PMID: 36177774 Free PMC article.

8

Second Primary Malignancy Risk in Multiple Myeloma from 1975 to 2018.

Wang J, Lv C, Zhou M, Xu JY, Chen B, Wan Y. Wang J, et al. Among authors: lv c. Cancers (Basel). 2022 Oct 7;14(19):4919. doi: 10.3390/cancers14194919. Cancers (Basel). 2022. PMID: 36230842 Free PMC article.

9

Developing mRNA signatures as a novel prognostic biomarker predicting high risk multiple myeloma.

Wang J, Guo L, Lv C, Zhou M, Wan Y. Wang J, et al. Among authors: lv c. Front Oncol. 2023 Feb 23;13:1105196. doi: 10.3389/fonc.2023.1105196. eCollection 2023. Front Oncol. 2023. PMID: 36910651 Free PMC article.

10

[Changes of Peripheral Blood Marrow-Derived Suppressor Cell Level after Chemotherapy Induction Remission by VDLP Regimen and Their Relationship with Immune System in B-ALL Children].

Guo XM, Fang YJ, Lv CL, Wang YR, Sun XY. Guo XM, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Dec;25(6):1611-1614. doi: 10.7534/j.issn.1009-2137.2017.06.005. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017. PMID: 29262884 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,109 results

Search Page

Filters